동향
동향 내용
Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies.
분류 drug discovery 조회 1447
발행년도 2015 등록일 2015-10-03
출처 Drug Discov Today (바로가기)
Drugs that covalently bond to their biological targets have a long history in drug discovery. A look at drug approvals in recent years suggests that covalent drugs will continue to make impacts on human health for years to come. Although fraught with concerns about toxicity, the high potencies and prolonged effects achievable with covalent drugs might result in less-frequent drug dosing and in wide therapeutic margins for patients.
 
(후략)

목록



[추천 메일 발송]
추천 메일 발송
받는 분 이메일 @
추천인
리스트 이전글과 다음글
이전글이전글 Acoustic Dispensing Preserves the Potency of Therapeutic Peptides throughout the Entire Drug Discovery Workflow.
다음글다음글 Target-based molecular modeling strategies for schistosomiasis drug discovery.